<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03566157</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-17T13:22:30+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation</title>
            <author role="aut">
              <persName>
                <forename type="first">Sylvie</forename>
                <surname>Perreault</surname>
              </persName>
              <idno type="halauthorid">2425671-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Alice</forename>
                <surname>Dragomir</surname>
              </persName>
              <idno type="halauthorid">2425672-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Robert</forename>
                <surname>Cote</surname>
              </persName>
              <idno type="halauthorid">2425673-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Aurelie</forename>
                <surname>Lenglet</surname>
              </persName>
              <email type="md5">6084ec9951b986bb76aeb330ea1092e2</email>
              <email type="domain">u-picardie.fr</email>
              <idno type="idhal" notation="string">aurelie-lenglet</idno>
              <idno type="idhal" notation="numeric">1263337</idno>
              <idno type="halauthorid" notation="string">2419524-1263337</idno>
              <idno type="IDREF">https://www.idref.fr/117459542</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/FJA-6228-2022</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/CEY-0304-2022</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/FJA-6228-2022</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/CEY-0304-2022</idno>
              <affiliation ref="#struct-533000"/>
              <affiliation ref="#struct-300535"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Simon</forename>
                <forename type="middle">De</forename>
                <surname>Denus</surname>
              </persName>
              <idno type="halauthorid">2425674-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Marc</forename>
                <surname>Dorais</surname>
              </persName>
              <idno type="halauthorid">2425675-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Brian</forename>
                <surname>White-Guay</surname>
              </persName>
              <idno type="halauthorid">2425676-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">James</forename>
                <surname>Brophy</surname>
              </persName>
              <idno type="idhal" notation="numeric">802089</idno>
              <idno type="halauthorid" notation="string">2012181-802089</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-8049-6875</idno>
              <affiliation ref="#struct-493900"/>
              <affiliation ref="#struct-134741"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Mireille E.</forename>
                <surname>Schnitzer</surname>
              </persName>
              <idno type="halauthorid">2425677-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Marie-Pierre</forename>
                <surname>Dube</surname>
              </persName>
              <idno type="idhal" notation="numeric">807985</idno>
              <idno type="halauthorid" notation="string">2243919-807985</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-8442-4393</idno>
              <affiliation ref="#struct-419276"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jean-Claude</forename>
                <surname>Tardif</surname>
              </persName>
              <idno type="halauthorid">711273-0</idno>
              <affiliation ref="#struct-419276"/>
              <affiliation ref="#struct-302452"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Louise</forename>
                <surname>DESSAIVRE</surname>
              </persName>
              <email type="md5">685d55eef963fb90de2023edc9d11c27</email>
              <email type="domain">u-picardie.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2022-02-11 13:46:00</date>
              <date type="whenModified">2024-07-30 13:08:03</date>
              <date type="whenReleased">2022-02-11 13:46:00</date>
              <date type="whenProduced">2022</date>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795908"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="799781">
                <persName>
                  <forename>Louise</forename>
                  <surname>DESSAIVRE</surname>
                </persName>
                <email type="md5">685d55eef963fb90de2023edc9d11c27</email>
                <email type="domain">u-picardie.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03566157</idno>
            <idno type="halUri">https://u-picardie.hal.science/hal-03566157</idno>
            <idno type="halBibtex">perreault:hal-03566157</idno>
            <idno type="halRefHtml">&lt;i&gt;Frontiers in Pharmacology&lt;/i&gt;, 2022, 12, &lt;a target="_blank" href="https://dx.doi.org/10.3389/fphar.2021.812018"&gt;&amp;#x27E8;10.3389/fphar.2021.812018&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Frontiers in Pharmacology, 2022, 12, &amp;#x27E8;10.3389/fphar.2021.812018&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-PICARDIE">Université de Picardie Jules Verne</idno>
            <idno type="stamp" n="U-PICARDIE">Université de Picardie Jules Verne</idno>
            <idno type="stamp" n="MP3CV" corresp="U-PICARDIE">Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Sylvie</forename>
                    <surname>Perreault</surname>
                  </persName>
                  <idno type="halauthorid">2425671-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Alice</forename>
                    <surname>Dragomir</surname>
                  </persName>
                  <idno type="halauthorid">2425672-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Robert</forename>
                    <surname>Cote</surname>
                  </persName>
                  <idno type="halauthorid">2425673-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Aurelie</forename>
                    <surname>Lenglet</surname>
                  </persName>
                  <email type="md5">6084ec9951b986bb76aeb330ea1092e2</email>
                  <email type="domain">u-picardie.fr</email>
                  <idno type="idhal" notation="string">aurelie-lenglet</idno>
                  <idno type="idhal" notation="numeric">1263337</idno>
                  <idno type="halauthorid" notation="string">2419524-1263337</idno>
                  <idno type="IDREF">https://www.idref.fr/117459542</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/FJA-6228-2022</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/CEY-0304-2022</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/FJA-6228-2022</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/CEY-0304-2022</idno>
                  <affiliation ref="#struct-533000"/>
                  <affiliation ref="#struct-300535"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Simon</forename>
                    <forename type="middle">De</forename>
                    <surname>Denus</surname>
                  </persName>
                  <idno type="halauthorid">2425674-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Marc</forename>
                    <surname>Dorais</surname>
                  </persName>
                  <idno type="halauthorid">2425675-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Brian</forename>
                    <surname>White-Guay</surname>
                  </persName>
                  <idno type="halauthorid">2425676-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">James</forename>
                    <surname>Brophy</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">802089</idno>
                  <idno type="halauthorid" notation="string">2012181-802089</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-8049-6875</idno>
                  <affiliation ref="#struct-493900"/>
                  <affiliation ref="#struct-134741"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Mireille E.</forename>
                    <surname>Schnitzer</surname>
                  </persName>
                  <idno type="halauthorid">2425677-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Marie-Pierre</forename>
                    <surname>Dube</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">807985</idno>
                  <idno type="halauthorid" notation="string">2243919-807985</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-8442-4393</idno>
                  <affiliation ref="#struct-419276"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jean-Claude</forename>
                    <surname>Tardif</surname>
                  </persName>
                  <idno type="halauthorid">711273-0</idno>
                  <affiliation ref="#struct-419276"/>
                  <affiliation ref="#struct-302452"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">73307</idno>
                <idno type="issn">1663-9812</idno>
                <title level="j">Frontiers in Pharmacology</title>
                <imprint>
                  <publisher>Frontiers</publisher>
                  <biblScope unit="volume">12</biblScope>
                  <date type="datePub">2022</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3389/fphar.2021.812018</idno>
              <idno type="pubmedcentral">PMC8795908</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Aims: Observational studies of various dose levels of direct oral anticoagulants (DOACs) for patients with atrial fibrillation (AF) found that a high proportion of patients received a dose lower than the target dose tested in randomized controlled trials. There is a need to compare low-dose DOACs with warfarin or other DOACs on effectiveness and safety.Methods: Using administrative data from Quebec province, Canada, we built a cohort of new warfarin or DOAC users discharged from hospital between 2011 and 2017. We determined CHA(2)DS(2)-VASc and HAS-BLED scores, and comorbidities for 3-year prior cohort entry. The primary effectiveness endpoint was a composite of ischemic stroke/systemic embolism (SE), and secondary outcomes included a safety composite of major bleeding (MB) events and effectiveness composite (stroke/SE, death) at 1-year follow-up. We contrasted each low-dose DOAC with warfarin or other DOACs as references using inverse probability of treatment weighting to estimate marginal Cox hazard ratios (HRs).Results: The cohort comprised 22,969 patients (mean age: 80-86). We did not find a significant risk reduction for the stroke/SE primary effectiveness endpoint for DOACs vs. warfarin; however, we observed a significantly lower risk for low-dose dabigatran vs. warfarin (HR [95%CI]: 0.59 [0.42-0.81]) for effectiveness composite, mainly due to a lower death rate. The differences in effectiveness and safety composites between low-dose rivaroxaban vs. warfarin were not significant. However, low-dose apixaban had a better safety composite (HR: 0.68 [0.53-0.88]) vs. warfarin. Comparisons of dabigatran vs. apixaban showed a lower risk of stroke/SE (HR: 0.53 [0.30-0.93]) and a 2-fold higher risk of MB. The MB risk was higher for rivaroxaban than for apixaban (HR: 1.58 [1.09-2.29]).Conclusions: The results of this population-based study suggest that low-dose dabigatran has a better effective composite than warfarin. Compared with apixaban, low-dose dabigatran had a better effectiveness composite but a worse safety profile. Low-dose apixaban had a better safety composite than warfarin and other low-dose DOACs. Given that the comparative effectiveness and safety seem to vary from one DOAC to another, pharmacokinetic data for specific populations are now warranted.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-533000" status="VALID">
          <idno type="IdRef">195403800</idno>
          <idno type="RNSR">201220168Z</idno>
          <idno type="ROR">https://ror.org/00bgnvd66</idno>
          <orgName>Mécanismes physiopathologiques et conséquences des calcifications cardiovasculaires - UR UPJV 7517</orgName>
          <orgName type="acronym">MP3CV</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>Université de Picardie Jules Verne - Centre de Recherche Universitaire en Santé (CURS) - CHU Sud - rue Renée Laennec - 80054 Amiens Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://mp3cv.u-picardie.fr/accueil-mp3cv-422954.kjsp</ref>
          </desc>
          <listRelation>
            <relation name="UR7517" active="#struct-300258" type="direct"/>
            <relation name="U1088" active="#struct-300535" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300535" status="VALID">
          <orgName>CHU Amiens-Picardie</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-493900" status="VALID">
          <idno type="ROR">https://ror.org/04cpxjv19</idno>
          <orgName>McGill University Health Center [Montreal]</orgName>
          <orgName type="acronym">MUHC</orgName>
          <desc>
            <address>
              <addrLine>1001 Décarie Boulevard, Montreal, QC H4A 3J1</addrLine>
              <country key="CA"/>
            </address>
            <ref type="url">https://muhc.ca/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-134741" status="VALID">
          <idno type="ROR">https://ror.org/01pxwe438</idno>
          <orgName>McGill University = Université McGill [Montréal, Canada]</orgName>
          <desc>
            <address>
              <addrLine>845, rue Sherbrooke O. Montréal (Québec) Canada H3A 0G4</addrLine>
              <country key="CA"/>
            </address>
            <ref type="url">http://www.mcgill.ca/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-419276" status="VALID">
          <idno type="ROR">https://ror.org/03vs03g62</idno>
          <orgName>Montreal Heart Institute - Institut de Cardiologie de Montréal</orgName>
          <desc>
            <address>
              <addrLine>5000 Rue Bélanger, Montréal, QC H1T 1C8, Canada</addrLine>
              <country key="CA"/>
            </address>
            <ref type="url">https://www.icm-mhi.org/en/montreal-heart-institute</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-302452" status="VALID">
          <idno type="ROR">https://ror.org/0161xgx34</idno>
          <orgName>Université de Montréal</orgName>
          <orgName type="acronym">UdeM</orgName>
          <desc>
            <address>
              <addrLine>2900 Boulevard Edouard-Montpetit, Montréal, QC H3T 1J4</addrLine>
              <country key="CA"/>
            </address>
            <ref type="url">https://www.umontreal.ca/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300258" status="VALID">
          <idno type="IdRef">026403714</idno>
          <idno type="ISNI">0000 0001 0789 1385</idno>
          <idno type="ROR">https://ror.org/01gyxrk03</idno>
          <orgName>Université de Picardie Jules Verne</orgName>
          <orgName type="acronym">UPJV</orgName>
          <desc>
            <address>
              <addrLine>Chemin du Thil - 80000 Amiens</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.u-picardie.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>